Aster DM Healthcare Ltd

Aster DM Healthcare announced that the Board of Directors of the Company at its meeting held on 20 May 2025, inter alia, have recommended the final dividend of Rs 1 per equity Share (i.e. 10%) , subject to the approval of the shareholders.Powered by Capital Market - Live

Net profit of Aster DM Healthcare reported to Rs 79.02 crore in the quarter ended March 2025 as against net loss of Rs 24.03 crore during the previous quarter ended March 2024. Sales rose 2.75% to Rs 1000.34 crore in the quarter ended March 2025 as against Rs 973.59 crore during the previous quarter ended March 2024. For the full year,net profit rose 4059.83% to Rs 5377.83 crore in the year ended March 2025 as against Rs 129.28 crore during the previous year ended March 2024. Sales rose 11.88% to Rs 4138.46 crore in the year ended March 2025 as against Rs 3698.90 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales1000.34973.59 3 4138.463698.90 12 OPM %18.2016.07 -18.0215.32 - PBDT180.91130.68 38 770.04481.16 60 PBT116.9672.32 62 521.20261.19 100 NP79.02-24.03 LP 5377.83129.28 4060 Powered by Capital Market - Live

Aster DM Healthcare will hold a meeting of the Board of Directors of the Company on 20 May 2025.Powered by Capital Market - Live

The proposed hospital will have an estimated bed capacity of approximately 430 beds. The company would install 300 beds by FY27 and the remaining 130 beds by FY29. The aforementioned lease agreement is with BREN Corporation and 5 other landowners. The agreement is for a period of 30 years from lease commencement date. It has a lock-in period of 30 years for the lessor and 12 years for the lessee. The company shall be obliged to pay rent based on per square feet of chargeable area plus applicable taxes. It would also be required to make an interest free refundable security deposit of Rs 58.65 crore. The project would entail an investment of Rs 480 crore and would be funded using bank loans and internal accruals. Offering the investment rationale, the company stated: Establishing a comprehensive multi-specialty hospital in South-East Bangalore offers a strategic opportunity to address the growing healthcare needs of a rapidly expanding population, driven by urbanization and an increasing middle class with greater disposable income. Sarjapur is projected to become the next IT hub in Bangalore making it an ideal location for specialized multi-specialty hospital with comprehensive cancer care. This project is well-positioned to serve an essential market need while capitalizing on the location's proximity to already established IT corridors.' Aster DM Healthcare is primarily involved in the operations of healthcare facilities, retail pharmacies, and providing consultancy in areas relating to healthcare. The company's consolidated net profit had declined 68.31% to Rs 56.79 crore despite a 9.97% increase in revenue to Rs 1,049.81 crore in Q3 FY25 as compared with Q3 FY24. The scrip has fallen 1.03% to currently trade at Rs 514.05 on the BSE. Powered by Capital Market - Live

Aster DM Healthcare has received the approval from Competition Commission of India (CCI) vide letter dated 15 April 2025 for the proposed transaction detailed below: 1. Acquisition of 1,90,46,028 equity shares of the face value of Rs 10 each held by BCP Asia II TopCo IV (BCP) and Centella Mauritius Holdings (Centella) and together with BCP, (QCIL Shareholders) in Quality Care India (QCIL) for consideration other than cash, being the issuance and allotment of 1,86,07,969 equity shares of the Company of the face value of Rs 10 each fully paid up, on a preferential basis to the QCIL Shareholders (Share Swap); 2. A scheme of amalgamation (Scheme) between the Company and QCIL and their respective shareholders and creditors under Section 230 to 232 of the Companies Act, 2013 and the rules framed thereunder read with relevant circulars and regulations of SEBI, and other applicable laws, for amalgamation of QCIL into the Company by way of merger (by absorption) as a going concern in consideration for the issuance and allotment of the equity shares of the Company to the shareholders of QCIL (other than the Company) in accordance with the share exchange ratio as stipulated in the Scheme (Merger and together with Share Swap, the Proposed Transactions).  Powered by Capital Market - Live

Bayer CropScience Ltd, Timken India Ltd, DCM Shriram Ltd, Indian Overseas Bank are among the other stocks to see a surge in volumes on NSE today, 28 March 2025.Aster DM Healthcare Ltd saw volume of 154.37 lakh shares by 14:14 IST on NSE, a 24.95 fold spurt over two-week average daily volume of 6.19 lakh shares. The stock increased 6.19% to Rs.481.40. Volumes stood at 9.37 lakh shares in the last session.Bayer CropScience Ltd saw volume of 3.58 lakh shares by 14:14 IST on NSE, a 12.08 fold spurt over two-week average daily volume of 29657 shares. The stock increased 4.96% to Rs.4,942.00. Volumes stood at 86238 shares in the last session.Timken India Ltd notched up volume of 8.36 lakh shares by 14:14 IST on NSE, a 6.83 fold spurt over two-week average daily volume of 1.22 lakh shares. The stock rose 0.73% to Rs.2,729.45. Volumes stood at 3.79 lakh shares in the last session.DCM Shriram Ltd notched up volume of 6.51 lakh shares by 14:14 IST on NSE, a 6.5 fold spurt over two-week average daily volume of 1.00 lakh shares. The stock slipped 0.71% to Rs.1,096.00. Volumes stood at 4.14 lakh shares in the last session.Indian Overseas Bank clocked volume of 372.94 lakh shares by 14:14 IST on NSE, a 4.42 times surge over two-week average daily volume of 84.31 lakh shares. The stock lost 6.47% to Rs.39.05. Volumes stood at 193.9 lakh shares in the last session.Powered by Capital Market - Live

Bayer CropScience Ltd, Mahindra Holidays & Resorts India Ltd, Timken India Ltd, Carborundum Universal Ltd are among the other stocks to see a surge in volumes on BSE today, 28 March 2025.Aster DM Healthcare Ltd registered volume of 17.76 lakh shares by 10:47 IST on BSE, a 76.46 fold spurt over two-week average daily volume of 23225 shares. The stock rose 2.12% to Rs.462.85. Volumes stood at 24618 shares in the last session.Bayer CropScience Ltd saw volume of 6244 shares by 10:47 IST on BSE, a 4.74 fold spurt over two-week average daily volume of 1317 shares. The stock increased 7.46% to Rs.5,070.70. Volumes stood at 1823 shares in the last session.Mahindra Holidays & Resorts India Ltd witnessed volume of 46794 shares by 10:47 IST on BSE, a 3.51 times surge over two-week average daily volume of 13328 shares. The stock increased 0.77% to Rs.295.00. Volumes stood at 49993 shares in the last session.Timken India Ltd notched up volume of 7923 shares by 10:47 IST on BSE, a 3.15 fold spurt over two-week average daily volume of 2513 shares. The stock rose 5.90% to Rs.2,875.00. Volumes stood at 7320 shares in the last session.Carborundum Universal Ltd clocked volume of 61602 shares by 10:47 IST on BSE, a 2.99 times surge over two-week average daily volume of 20637 shares. The stock gained 5.64% to Rs.1,019.40. Volumes stood at 36592 shares in the last session.Powered by Capital Market - Live

However, revenue from operations jumped 9.96% year on year (YoY) to Rs 1,049.81 crore during the quarter ended 31 December 2024. Profit before tax rallied 32.98% to Rs 101.88 crore in Q3 of FY25, from Rs 76.61 crore posted in the corresponding quarter last year. EBITDA stood at Rs 202 crore in the December 2024 quarter, up 20% as compared with Rs 168 crore in Q3 FY24. EBITDA margin expanded to 19.3% in Q3 FY25 as against 17.7% in Q3 FY24. Dr. Azad Moopen, Founder and Chairman, Aster DM Healthcare, said: 'We are pleased with the momentum built in the third quarter of FY25, which reflects our unwavering focus on operational excellence and capacity enhancement. For 9M FY25, our India business achieved 15% YoY growth, reaching Rs 3,138 crore, driven by increased patient volumes and growth in ARPOB. The operating EBITDA grew by 35% YoY to Rs 613 crore, and adjusted net profits (post NCI and excluding merger transaction cost) grew by 65% YoY to Rs 251 crore for 9M FY25. A consistent growth across our core businesses, combined with strategic cost optimization, has significantly strengthened our margins, with 9MFY25 operating EBITDA margins standing at 19.5%.' Dr. Moopen further added, 'As we expand, with plans to surpass 6,800 beds by FY27, Aster DM Healthcare is well-positioned to meet the increasing demand for advanced healthcare in India. I am happy to announce that Aster DM Healthcare was recently honored at the ASSOCHAM Healthcare Awards 2024, winning the title of Best Multispecialty Hospital-Group, while Aster DM Foundation secured a 1st runner-up for Best CSR Excellence in Healthcare.'. Meanwhile, the company has received shareholder approval for the issuance of equity shares on a preferential basis to eligible shareholders of Quality Care India (QCIL) and for the change in the company's registered office. The application seeking approval for the preferential allotment to QCIL's eligible shareholders, the acquisition of approximately a 5% stake in QCIL, and the subsequent merger has been filed with the Competition Commission of India (CCI) for their approval. Additionally, an application has been submitted to the stock exchange for approval of the merger, and the company will soon file the application for the change in registered office with the Regional Director, South-East Region, Telangana. The closing of the transaction is pending the fulfillment of regulatory and compliance requirements, including the receipt of no-objection letters from the stock exchanges, as well as approvals from CCI and the National Company Law Tribunal (NCLT). Further, the board has declared an interim dividend of Rs 4 per share, as on the record date, i.e., 7 February 2025. The date of payment of the interim dividend will be on or before Monday, 10 February 2025. Aster DM Healthcare is primarily involved in the operations of healthcare facilities, retail pharmacies, and providing consultancy in areas relating to healthcare. Powered by Capital Market - Live

Aster DM Healthcare announced that the Board of Directors of the Company at its meeting held on 31 January 2025, inter alia, have recommended the interim dividend of Rs 4 per equity Share (i.e. 40%) , subject to the approval of the shareholders.Powered by Capital Market - Live

Net profit of Aster DM Healthcare declined 68.31% to Rs 56.79 crore in the quarter ended December 2024 as against Rs 179.21 crore during the previous quarter ended December 2023. Sales rose 9.97% to Rs 1049.81 crore in the quarter ended December 2024 as against Rs 954.67 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales1049.81954.67 10 OPM %17.6815.63 - PBDT187.81133.12 41 PBT125.6076.61 64 NP56.79179.21 -68 Powered by Capital Market - Live